Literature DB >> 12424626

Characterization of a nuclear-factor-kappa B (NFkappaB) genetic marker in type 1 diabetes (T1DM) families.

T Gylvin1, R Bergholdt, J Nerup, F Pociot.   

Abstract

Cytokine-induced beta-cell death is an important factor in the pathogenesis of type 1 diabetes mellitus (T1DM). The transcription factor NFkappaB plays an important role in cytokine-induced gene activation. Hence, NFKB1 is a possible candidate gene for T1DM disposition. A polymorphic (CA) dinucleotide repeat microsatellite has been identified near the NFKB1 gene. In a recent case-control study certain alleles of this NFKB1 microsatellite marker showed strong association to T1DM. The aim of our study was to investigate whether the association between the NFKB1 marker and T1DM could be confirmed in a Danish family collection. No T1DM association for any allele of the NFKB1 microsatellite marker could however be demonstrated in Danish T1DM families. In conclusion, we could not confirm the highly significant T1DM association of certain alleles of the NFKB1 marker previously reported.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12424626     DOI: 10.1038/sj.gene.6363916

Source DB:  PubMed          Journal:  Genes Immun        ISSN: 1466-4879            Impact factor:   2.676


  4 in total

Review 1.  SUMO wrestling with type 1 diabetes.

Authors:  Manyu Li; Dehuang Guo; Carlos M Isales; Decio L Eizirik; Mark Atkinson; Jin-Xiong She; Cong-Yi Wang
Journal:  J Mol Med (Berl)       Date:  2005-04-02       Impact factor: 4.599

2.  Is a new immune response mediator in the NF-kappaB pathway--SUMO-4--related to type 1 diabetes?

Authors:  Charles Sia
Journal:  Rev Diabet Stud       Date:  2005-08-10

3.  Genetic and Molecular Basis of QTL of Diabetes in Mouse: Genes and Polymorphisms.

Authors:  Peng Gao; Yan Jiao; Qing Xiong; Cong-Yi Wang; Ivan Gerling; Weikuan Gu
Journal:  Curr Genomics       Date:  2008       Impact factor: 2.236

4.  Analysis of polymorphisms in 16 genes in type 1 diabetes that have been associated with other immune-mediated diseases.

Authors:  Deborah J Smyth; Joanna M M Howson; Felicity Payne; Lisa M Maier; Rebecca Bailey; Kieran Holland; Christopher E Lowe; Jason D Cooper; John S Hulme; Adrian Vella; Ingrid Dahlman; Alex C Lam; Sarah Nutland; Neil M Walker; Rebecca C J Twells; John A Todd
Journal:  BMC Med Genet       Date:  2006-03-06       Impact factor: 2.103

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.